The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our condensed consolidated
financial statements and the related notes and other financial information
included elsewhere in this Quarterly Report on Form 10-Q and the Annual Report
on Form 10-K. In addition to historical consolidated financial information, the
following discussion contains forward-looking statements that reflect our plans,
estimates, and beliefs. Our actual results may differ materially from those
discussed in the forward-looking statements as a result of various factors,
including those set forth in Part II, Item 1A. Risk Factors and Note Regarding
Forward-Looking Statements included elsewhere in this Quarterly Report on Form
10-Q and in the Annual Report on Form 10-K.
THE COMPANY
BRP Group, Inc. ("BRP Group," the "Company," "we," "us" or "our") is a rapidly
growing independent insurance distribution firm delivering solutions that give
our Clients the peace of mind to pursue their purpose, passion and dreams. We
support our Clients, Colleagues, Insurance Company Partners and communities
through the deployment of vanguard resources and capital to drive organic and
inorganic growth. We are innovating the industry by taking a holistic and
tailored approach to risk management, insurance and employee benefits. Our
growth plan includes increased geographic representation across the U.S.,
expanded client value propositions and new lines of insurance to meet the needs
of evolving lifestyles, business risks and healthcare funding. We are a
destination employer supported by an award-winning culture, powered by
exceptional people and fueled by industry-leading growth and innovation.
We represent over 450,000 Clients across the United States and internationally.
Our more than 700 Colleagues include approximately 200 Risk Advisors, who are
fiercely independent, relentlessly competitive and "insurance geeks." We have
over 50 offices, all of which are equipped to provide diversified products and
services to empower our clients at every stage through our four Operating
Groups.
•      Middle Market provides expertly-designed private risk management,
       commercial risk management and employee benefits solutions for
       mid-to-large-size businesses and high net worth individuals, as well as
       their families.

• MainStreet offers personal insurance, commercial insurance and life and


       health solutions to individuals and businesses in their communities.


•      Medicare offers consultation for government assistance programs and

solutions to seniors and Medicare-eligible individuals through a network


       of agents.


•      Specialty delivers specialty insurers, professionals, individuals and

niche industry businesses expanded access to exclusive specialty markets,

capabilities and programs requiring complex underwriting and placement.




In 2011, we adopted the "Azimuth" as our corporate constitution. Named after a
historical navigation tool used to find "true north," the Azimuth asserts our
core values, business basics and stakeholder promises. The ideals encompassed by
the Azimuth support our mission to deliver indispensable, tailored insurance and
risk management insights and solutions to our clients. We strive to be regarded
as the preeminent insurance advisory firm fueled by relationships, powered by
people and exemplified by client adoption and loyalty. This type of environment
is upheld by the distinct vernacular we use to describe our services and
culture. We are a firm, instead of an agency; we have Colleagues, instead of
employees; we have Risk Advisors, instead of producers/agents. We serve clients
instead of customers and we refer to our acquisitions as Partnerships.
The insurance brokerage market is seasonal and our results of operations are
somewhat affected by seasonal trends. Our Adjusted EBITDA and Adjusted EBITDA
Margins are typically highest in the first quarter and lowest in the fourth
quarter. This variation is primarily due to fluctuations in our revenues, while
overhead remains consistent throughout the year. Our revenues are generally
highest in the first quarter due to the impact of contingent payments received
in the first quarter from Insurance Company Partners that we cannot readily
estimate before receipt without the risk of significant reversal and a higher
degree of first quarter policy commencements and renewals in Medicare and
certain Middle Market lines of business such as employee benefits and
commercial. In addition, a higher proportion of our first quarter revenue is
derived from our highest margin businesses. As discussed further below, the
COVID-19 pandemic may skew these general trends due to reduced amounts of new
business and reductions in business from existing Clients related to the
pandemic.
Partnerships can significantly impact Adjusted EBITDA and Adjusted EBITDA
Margins in a given year and may increase the amount of seasonality within the
business, especially results attributable to Partnerships that have not been
fully integrated into our business or owned by us for a full year.

                                                                            

24

--------------------------------------------------------------------------------

PARTNERSHIPS


We utilize strategic acquisitions, which we refer to as Partnerships, to
complement and expand our business. The financial impact of Partnerships may
affect the comparability of our results from period to period. Our acquisition
strategy also entails certain risks, including the risks that we may not be able
to successfully source, close, integrate and effectively manage businesses that
we acquire. To mitigate that risk, we have a professional team focused on
finding new Partners and integrating new Partnerships. We plan to execute on
numerous Partnerships annually as it is a key pillar in our long-term growth
strategy over the next ten years.
We completed four Partnerships for an aggregate purchase price of $59.7 million
during the three months ended March 31, 2020 and one Partnership for an
aggregate purchase price of $37.0 million during the three months ended March
31, 2019. The most significant Partnerships that we have completed during 2020
are discussed in greater detail below. For additional information on the
Partnerships that we have completed during 2020, see Note 3 to our condensed
consolidated financial statements included in Part I, Item 1. Financial
Statements of this report.
Effective January 1, 2020, we purchased certain assets and intellectual and
intangible rights and assumed certain liabilities of Lanier, a Middle Market
Partner for cash consideration of $24.5 million and fair value of noncontrolling
interest of $6.1 million and fair value of contingent earnout consideration of
$1.6 million. The Partnership was made to expand our Middle Market presence in
the healthcare, higher education, construction, property and non-profit
businesses throughout Florida and other states.
Effective January 1, 2020, we purchased certain assets and intellectual and
intangible rights and assumed certain liabilities of Highland, a Specialty
Partner, for cash consideration of $6.6 million, fair value of noncontrolling
interest of $4.5 million and fair value of contingent earnout consideration of
$788,000. The Partnership was made to expand our Specialty presence in the
healthcare and cyber insurance businesses and to add capabilities within the
real estate business.
NOVEL CORONAVIRUS (COVID-19)
In March 2020, the World Health Organization declared a novel strain of the
coronavirus, COVID-19, a pandemic. This COVID-19 outbreak has become
increasingly widespread and severely restricted the level of economic activity
around the world. In response to this outbreak, the governments of many
countries, states, cities and other geographic regions, including in the United
States, have taken preventive or protective actions, such as imposing
restrictions on travel and business operations and advising or requiring
individuals to limit or forgo their time outside of their homes. In the United
States, temporary closures of businesses have been ordered and numerous other
businesses have temporarily closed voluntarily.
Our Clients and Colleagues are our first priority and we have taken steps to
ensure their safety by implementing a remote work environment for the majority
of our Colleagues without disruption to Client service. We have funded the BRP
True North Colleague Fund to assist with relief for COVID-19 and other
qualifying disasters for our Colleagues experiencing extraordinary hardship. We
are currently matching Colleague donations dollar-for dollar.
We intend to continue to execute on our strategic plans and operational
initiatives during the pandemic. However, given the uncertainty regarding the
spread and severity of COVID-19, the duration and scope of the government
shutdowns, the nature of societal responses and the adverse effects on the
national and global economy, the related financial impact on our business cannot
be accurately predicted at this time. The national and global economies have
rapidly contracted as a result of COVID-19. The decreased level of economic
activity is leading to, and is likely to continue to lead to, a decline in
exposure units and rising unemployment. In addition, the uncertainties
associated with the protective and preventive measures being put in place or
recommended by both governmental entities and other businesses, among other
uncertainties, may result in delays or modifications to our plans and
initiatives. See Part II, Item 1A. "Risk Factors - The ongoing novel coronavirus
(COVID-19) pandemic could result in declines in business and increases in claims
that could adversely affect our business, financial condition and results of
operations."
RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019
The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our condensed consolidated
financial statements for the three months ended March 31, 2020 and the related
notes and other financial information included elsewhere in this report. In
addition to historical financial information, the following discussion and
analysis contains forward-looking statements that involve risks, uncertainties
and assumptions. Our actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a
result of many factors, including those discussed under Part II, Item 1A. Risk
Factors.

                                                                              25

--------------------------------------------------------------------------------

The following is a discussion of our consolidated results of operations for each of the three months ended March 31, 2020 and 2019.


                                                     For the Three Months Ended March
                                                                    31,
(in thousands)                                            2020               2019         Variance
Revenues:
Commissions and fees                                 $    54,159         $    29,837     $  24,322

Operating expenses:
Commissions, employee compensation and benefits           34,548              16,286        18,262
Other operating expenses                                   8,885               4,002         4,883
Amortization expense                                       3,596                 876         2,720
Change in fair value of contingent consideration           1,661              (2,786 )       4,447
Depreciation expense                                         165                 127            38
Total operating expenses                                  48,855              18,505        30,350

Operating income                                           5,304              11,332        (6,028 )

Interest expense, net                                       (585 )            (1,590 )       1,005

Income before income taxes                                 4,719               9,742        (5,023 )
Income tax provision                                          12                   -            12
Net income                                                 4,707               9,742        (5,035 )
Less: net income attributable to noncontrolling
interests                                                  3,239               9,742        (6,503 )
Net income attributable to BRP Group, Inc.           $     1,468         $  

- $ 1,468




Commissions and Fees
We earn commissions and fees by facilitating the arrangement between Insurance
Company Partners and individuals or businesses for the carrier to provide
insurance to the insured party. Our commissions and fees are usually a
percentage of the premium paid by the insured and generally depends on the type
of insurance, the particular Insurance Company Partner and the nature of the
services provided. Under certain arrangements with clients, we earn
pre-negotiated service fees in lieu of commissions. Additionally, we may also
receive from Insurance Company Partners a profit-sharing commission, or straight
override, which represent forms of variable consideration associated with the
placement of coverage and are based primarily on underwriting results, but may
also contain considerations for volume, growth or retention.
Commissions and fees increased by $24.3 million for the three months ended March
31, 2020 as compared to the same period of 2019. This increase was primarily
attributable to commissions and fees attributable to Partners acquired during
2019 and 2020 prior to their having reached the twelve-month owned mark (such
commissions and fees, the "Partnership Contribution"), which accounted for $22.9
million commissions and fees, in addition to $1.5 million of organic growth.

                                                                            

26

--------------------------------------------------------------------------------

Major Sources of Commissions and Fees The following table sets forth our commissions and fees by major source by amount for the periods indicated:


                                                  For the Three Months Ended
                                                           March 31,
(in thousands)                                        2020            2019         Variance
Direct bill revenue                              $     28,109     $   19,602     $    8,507
Agency bill revenue                                    16,429          4,570         11,859
Profit-sharing revenue                                  5,124          4,453            671
Policy fee and installment fee revenue                  3,382              -          3,382
Consulting and service fee revenue                        715            647             68
Other income                                              400            565           (165 )
Total commissions and fees                       $     54,159     $   29,837     $   24,322


Direct bill revenue represents commission revenue earned by providing insurance
placement services to clients, primarily for private risk management, commercial
risk management, employee benefits and Medicare insurance types. Direct bill
revenue increased by $8.5 million for the three months ended March 31, 2020 as
compared to the same period of 2019. This increase was primarily attributable to
the Partnership Contribution, which accounted for $6.9 million direct bill
revenue, in addition to organic growth. Organic growth for direct bill revenue
was negatively impacted by $0.2 million as a result of incremental cancellation
reserves related to COVID-19.
Agency bill revenue primarily represents commission revenue earned by providing
insurance placement services to clients wherein we act as an agent on behalf of
the Client. Agency bill revenue increased by $11.9 million for the three months
ended March 31, 2020 as compared to the same period of 2019. This increase was
primarily attributable to the Partnership Contribution, which accounted for
$11.1 million agency bill revenue, in addition to organic growth. Organic growth
for agency bill revenue was negatively impacted by $0.1 million as a result of
incremental cancellation reserves related to COVID-19.
Profit-sharing revenue represents bonus-type revenue that is earned by us as a
sales incentive provided by certain Insurance Company Partners. Profit-sharing
revenue increased by $0.7 million for the three months ended March 31, 2020 as
compared to the same period of 2019. This increase was primarily attributable to
the Partnership Contribution, which accounted for $1.3 million profit-sharing
revenue, offset in part by a decrease of $0.6 million in profit sharing revenue
generated by legacy businesses as a result of expected higher loss ratios in our
Middle Market and MainStreet Operating Groups. We expect higher loss ratios to
continue to reduce contingent revenue for our MainStreet business through June
2020 and increase base commissions and fees towards the end of 2020 and into
2021.
Policy fee and installment fee revenue represents revenue earned for acting in
the capacity of an MGA and providing payment processing and services and other
administrative functions on behalf of Insurance Company Partners. We earned $3.4
million of policy fee and installment fee revenue during the three months ended
March 31, 2020 from our "MGA of the Future," which was acquired April 1, 2019
and resides in our Specialty Operating Group.
Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits is our largest expense. It
consists of (a) base compensation comprising salary, bonuses and benefits paid
and payable to Colleagues, commissions paid to Colleagues and outside
commissions paid to others; and (b) equity-based compensation associated with
the grants of restricted interest awards to senior management, Risk Advisors and
executives. We expect to continue to experience a general rise in commissions,
employee compensation and benefits expense commensurate with expected growth in
our sales and headcount and as a result of increasing employee compensation
related to ongoing public company costs. We operate in competitive markets for
human capital and need to maintain competitive compensation levels as we expand
geographically and create new products and services.
Our compensation arrangements with our employees contain significant bonus or
commission components driven by the results of our operations. Therefore, as we
grow commissions and fees, we expect compensation costs to rise.
Commissions, employee compensation and benefits expenses increased by $18.3
million for the three months ended March 31, 2020 as compared to the same period
of 2019. This increase was primarily attributable to the Partnership
Contribution, which accounted for $14.5 million commissions, employee
compensation and benefits. In addition, we had increased compensation of $1.6
million as a result of 2019 hiring for new roles necessary as a public company
and $1.0 million related to share-based compensation expense.

                                                                            

27

--------------------------------------------------------------------------------




Other Operating Expenses
Other operating expenses include travel, accounting, legal and other
professional fees, placement fees, rent, office expenses, depreciation and other
costs associated with our operations. Our occupancy-related costs and
professional services expenses, in particular, generally increase or decrease in
relative proportion to the number of our employees and the overall size and
scale of our business operations. In addition, we are investing in the expansion
of our Tampa offices to accommodate our growth plans, which will result in an
increase to rent expense beginning in April 2020. Certain corporate expenses are
allocated to the Operating Groups.
Other operating expenses increased by $4.9 million for the three months ended
March 31, 2020 as compared to the same period of 2019. This increase was
primarily attributable to operating expenses such as additional rent and
increased software costs, professional fees, travel, and other expenses from the
Partnership Contribution, which accounted for $2.0 million other operating
expenses. In the first quarter of 2020, we had public company costs of $0.7
million and higher professional fees related to being a public company.
Amortization Expense
Amortization expense increased by $2.7 million for the three months ended March
31, 2020 as compared to the same period of 2019. This increase was driven by
amortization of $1.8 million related to intangible assets capitalized in
connection with the Millennial Specialty Insurance LLC "MSI" Partner, in
addition to amortization related to other Partners acquired since the first
quarter of 2019.
Change in Fair Value of Contingent Consideration
Change in fair value of contingent consideration was $1.7 million for the three
months ended March 31, 2020 as compared to $(2.8) million for the same period of
2019. The change in fair value of contingent consideration results from
fluctuations in the value of the relevant measurement basis, normally revenue or
EBITDA, of our Partners. We had significantly higher estimates for the
contingent earnout liabilities of the MSI and Foundation Insurance of Florida,
LLC ("Foundation Insurance") Partners during the first quarter of 2020 related
to growth of their business during the period under consolidation. We had lower
estimates for the contingent earnout liabilities of certain Partners during the
first quarter of 2019, particularly in the Middle Market business.
Interest Expense, Net
Interest expense, net decreased by $1.0 million for the three months ended March
31, 2020 as compared to the same period of 2019. This decrease was attributable
to a lower overall debt balance during the first quarter of 2020 compared to the
same period of 2019 as a result of our having paid off one of our credit
facilities in October 2019 in connection with our initial public offering.
NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA, Adjusted EBITDA Margin, Organic Revenue, Organic Revenue
Growth, Adjusted Net Income and Adjusted Diluted Earnings Per Share ("EPS"), are
not measures of financial performance under GAAP and should not be considered
substitutes for GAAP measures, including commissions and fees (for Organic
Revenue and Organic Revenue Growth), net income (loss) (for Adjusted EBITDA and
Adjusted EBITDA Margin) net income (loss) attributable to BRP Group, Inc. (for
Adjusted Net Income) or diluted EPS (for Adjusted Diluted EPS), which we
consider to be the most directly comparable GAAP measures. These non-GAAP
financial measures have limitations as analytical tools, and when assessing our
operating performance, you should not consider these non-GAAP financial measures
in isolation or as substitutes for commissions and fees, net income (loss) or
other consolidated income statement data prepared in accordance with GAAP. Other
companies in our industry may define or calculate these non-GAAP financial
measures differently than we do, and accordingly these measures may not be
comparable to similarly titled measures used by other companies.
Adjusted EBITDA eliminates the effects of financing, depreciation, amortization
and change in fair value of contingent consideration. We define Adjusted EBITDA
as net income (loss) before interest, taxes, depreciation, amortization, change
in fair value of contingent consideration and certain items of income and
expense, including share-based compensation expense, transaction-related
expenses related to Partnerships including severance, and certain non-recurring
costs, including those related to our initial public offering and loss on
modification and extinguishment of debt. We believe that Adjusted EBITDA is an
appropriate measure of operating performance because it eliminates the impact of
expenses that do not relate to business performance, and that the presentation
of this measure enhances an investor's understanding of our financial
performance.

                                                                            

28

--------------------------------------------------------------------------------




Adjusted EBITDA Margin is Adjusted EBITDA divided by commissions and fees.
Adjusted EBITDA is a key metric used by management and our board of directors to
assess our financial performance. We believe that Adjusted EBITDA is an
appropriate measure of operating performance because it eliminates the impact of
expenses that do not relate to business performance, and that the presentation
of this measure enhances an investor's understanding of our financial
performance. We believe that Adjusted EBITDA Margin is helpful in measuring
profitability of operations on a consolidated level.
Adjusted EBITDA and Adjusted EBITDA Margin have important limitations as
analytical tools. For example, Adjusted EBITDA and Adjusted EBITDA Margin:
•      do not reflect any cash capital expenditure requirements for the assets
       being depreciated and amortized that may have to be replaced in the
       future;

• do not reflect changes in, or cash requirements for, our working capital

needs;

• do not reflect the impact of certain cash charges resulting from matters

we consider not to be indicative of our ongoing operations;

• do not reflect the interest expense or the cash requirements necessary to


       service interest or principal payments on our debt;


•      do not reflect stock-based compensation expense and other non-cash
       charges; and


•      exclude certain tax payments that may represent a reduction in cash
       available to us.


We calculate Organic Revenue Growth based on commissions and fees for the
relevant period by excluding the first twelve months of commissions and fees
generated from new Partners. Organic Revenue Growth is the change in Organic
Revenue period-to-period, with prior period results adjusted for Organic
Revenues that were excluded in the prior period because the relevant Partners
had not yet reached the twelve-month owned mark, but which have reached the
twelve-month owned mark in the current period. For example, revenues from a
Partner acquired on June 1, 2019 are excluded from Organic Revenue for 2019.
However, after June 1, 2020, results from June 1, 2019 to December 31, 2019 for
such Partners are compared to results from June 1, 2020 to December 31, 2020 for
purposes of calculating Organic Revenue Growth in 2020. Organic Revenue Growth
is a key metric used by management and our board of directors to assess our
financial performance. We believe that Organic Revenue and Organic Revenue
Growth are appropriate measures of operating performance as they allow investors
to measure, analyze and compare growth in a meaningful and consistent manner.
Adjusted Net Income is presented for the purpose of calculating Adjusted Diluted
EPS. We define Adjusted Net Income as net income (loss) adjusted for
amortization, change in fair value of contingent consideration and certain items
of income and expense, including costs related to our initial public offering,
share-based compensation expense, transaction-related expenses related to
Partnerships including severance, and certain non-recurring costs that, in the
opinion of management, significantly affect the period-over-period assessment of
operating results, and the related tax effect of those adjustments.
Adjusted Diluted EPS measures our per share earnings excluding certain expenses
as discussed above and assuming all shares of Class B common stock were
exchanged for Class A common stock. Adjusted Diluted EPS is calculated as
Adjusted Net Income divided by adjusted dilutive weighted-average shares
outstanding. We believe Adjusted Diluted EPS is useful to investors because it
enables them to better evaluate per share operating performance across reporting
periods.

                                                                              29

--------------------------------------------------------------------------------




Adjusted EBITDA and Adjusted EBITDA Margin
The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net
income, which we consider to be the most directly comparable GAAP financial
measure to Adjusted EBITDA and Adjusted EBITDA Margin:
                                                                For the Three Months Ended March 31,
(in thousands, except percentages)                                  2020                     2019
Commissions and fees                                        $          54,159         $          29,837

Net income                                                  $           4,707         $           9,742
Adjustments to net income:
Amortization expense                                                    3,596                       876
Change in fair value of contingent consideration                        1,661                    (2,786 )
Share-based compensation                                                1,139                       130
Interest expense, net                                                     585                     1,590
Depreciation expense                                                      165                       127
Transaction-related Partnership expenses                                1,848                       257
Severance related to Partnership activity                                  53                         -
Offering expenses                                                           -                        38
Income tax provision                                                       12                         -
Other                                                                     266                       155
Adjusted EBITDA                                             $          14,032         $          10,129
Adjusted EBITDA Margin                                                     26 %                      34 %


Organic Revenue and Organic Revenue Growth
The following table reconciles Organic Revenue to commissions and fees, which we
consider to be the most directly comparable GAAP financial measure to Organic
Revenue:
                                           For the Three Months Ended March 

31,


(in thousands, except percentages)             2020                     

2019


Commissions and fees                   $          54,159         $          

29,837


Partnership commissions and fees (1)             (22,868 )                  (5,358 )
Organic Revenue                        $          31,291         $          

24,479


Organic Revenue Growth (2)             $           1,454         $          

2,693


Organic Revenue Growth % (2)                           5 %                  

12 %

__________

(1) Includes the first twelve months of such commissions and fees generated from

newly acquired Partners.

(2) Organic Revenue for the three months ended March 31, 2019 used to calculate

Organic Revenue Growth for the three months ended March 31, 2020 was $29.8

million, which is adjusted to reflect revenues from Partnerships that reached


    the twelve-month owned mark during the three months ended March 31, 2020.



                                                                              30

--------------------------------------------------------------------------------




Adjusted Net Income and Adjusted Diluted EPS
The following table reconciles Adjusted Net Income to net income attributable to
BRP Group, Inc. and reconciles Adjusted Diluted EPS to diluted earnings per
share attributable to BRP Group, Inc. Class A common stock:
                                                                        For the Three Months
(in thousands, except per share data)                                   Ended March 31, 2020
Net income attributable to BRP Group, Inc.                            $     

1,468


Net income attributable to noncontrolling interests                         

3,239


Amortization expense                                                        

3,596


Change in fair value of contingent consideration                            

1,661


Share-based compensation                                                    

1,139

Transaction-related Partnership expenses                                    

1,848


Amortization of deferred financing costs                                    

76


Severance related to Partnership activity                                            53
Other                                                                               266
Adjusted pre-tax income                                                          13,346
Adjusted income taxes (1)                                                         1,321
Adjusted Net Income                                                   $          12,025

Weighted-average shares of Class A common stock outstanding - diluted

19,816


Exchange of Class B shares (2)                                              

43,541


Adjusted dilutive weighted-average shares outstanding                            63,357

Adjusted Diluted EPS                                                  $            0.19

Diluted earnings per share                                            $     

0.07

Effect of exchange of Class B shares and net income attributable to noncontrolling interests per share

-


Other adjustments to net income per share                                   

0.14


Adjusted income taxes per share                                                   (0.02 )
Adjusted Diluted EPS                                                  $            0.19


___________

(1) Represents corporate income taxes at assumed effective tax rate of 9.9%

applied to adjusted pre-tax income.

(2) Assumes the full exchange of Class B shares for Class A common stock pursuant


    to the Amended LLC Agreement.




                                                                              31

--------------------------------------------------------------------------------




RESULTS OF OPERATIONS BY OPERATING GROUP
Commissions and Fees
In the Middle Market, MainStreet and Specialty Operating Groups, the Company
generates commissions and fees from insurance placement under both agency bill
and direct bill arrangements. In addition, the Company generates profit-sharing
income in each of those segments based on either the underlying Book of Business
or performance, such as loss ratios. In the Middle Market Operating Group only,
the Company generates fees from service fee and consulting arrangements. Service
fee arrangements are in place with certain customers in lieu of commission
arrangements.
In the Medicare Operating Group, BRP generates commissions and fees in the form
of direct bill insurance placement and marketing income. Marketing income is
earned through co-branded marketing campaigns with the Company's Insurance
Company Partners.
The following table sets forth our commissions and fees by Operating Group by
amount and as a percentage of our commissions and fees:
                                            For the Three Months Ended March 31,
                                         2020                                    2019                           Variance
                                                                                                                       Percent
                                                                                                                        Change
                                                                                                                      from Prior
(in thousands)              Amount         Percent of Business      Amount       Percent of Business      Amount         Year
Commissions and fees
by Operating Group
Middle Market           $      22,032                41 %         $  16,539                55 %         $   5,493           33 %
Specialty                      17,416                32 %             2,831                 9 %            14,585          n/m
MainStreet                      8,308                15 %             6,531                22 %             1,777           27 %
Medicare                        6,403                12 %             3,936                13 %             2,467           63 %
                        $      54,159                             $  29,837                             $  24,322


__________
n/m not meaningful


Commissions and fees increased across all Operating Groups for the three months
ended March 31, 2020 as compared to the same period of 2019. These increases
were primarily attributable to the Partnership Contribution, which accounted for
$5.0 million, $13.9 million, $1.4 million and $2.6 million commissions and fees
in the Middle Market, Specialty, MainStreet and Medicare Operating Groups,
respectively, during 2020. The remaining variances are attributable to organic
growth. Our Middle Market Operating Group is most likely to feel the impact of
the pandemic should the economic contraction persist and businesses act to
further reduce their workforces.
The Specialty Operating Group had higher contingent revenue related to organic
growth during the first quarter of 2020 as a result of its 2019 Partnership,
while the Middle Market and MainStreet Operating Groups had lower contingent
revenue related to organic growth during the same period related to poor loss
trends in our Florida-based personal lines businesses and private risk business
in 2019. We expect higher loss ratios to continue to reduce contingent revenue
for our MainStreet business through June 2020 and increase base commissions and
fees towards the end of 2020 and into 2021 for those Operating Groups.
Policies in force for Specialty's MSI Partnership grew by 107,147, or 36%, to
401,520 at March 31, 2020 from 294,373 at March 31, 2019. Since the MSI
Partnership was not completed until April 2019, the 36% policies in force growth
was calculated including periods during which MSI was not owned by the Company.

                                                                            

32

--------------------------------------------------------------------------------




Commissions, Employee Compensation and Benefits
The following table sets forth our commissions, employee compensation and
benefits by Operating Group by amount and as a percentage of our commissions,
employee compensation and benefits:
                                            For the Three Months Ended March 31,
                                         2020                                    2019                           Variance
                                                                                                                       Percent
                                                                                                                        Change
                                                                                                                      from Prior
(in thousands)              Amount         Percent of Business      Amount       Percent of Business      Amount         Year
Commissions, employee
compensation and
benefits by Operating
Group
Middle Market           $      12,620                37 %         $   8,596                53 %         $   4,024           47 %
Specialty                      12,801                37 %             2,553                16 %            10,248          n/m
MainStreet                      3,962                11 %             3,083                19 %               879           29 %
Medicare                        3,016                 9 %             1,688                10 %             1,328           79 %
Corporate and Other             2,149                 6 %               366                 2 %             1,783          n/m
                        $      34,548                             $  16,286                             $  18,262


__________
n/m not meaningful


Commissions, employee compensation and benefits expenses increased across all
Operating Groups for the three months ended March 31, 2020 as compared to the
same period of 2019. These increases were primarily attributable to the
Partnership Contribution, which accounted for $2.9 million, $9.7 million, $0.7
million and $1.2 million commissions, employee compensation and benefits
expenses in the Middle Market, Specialty, MainStreet and Medicare Operating
Groups, respectively, during 2020. Commissions, employee compensation and
benefits expenses also increased throughout the four Operating Groups as a
result of continued investments in Growth Services to support our growth, which
costs are allocated among the Operating Groups.
Commissions, employee compensation and benefits expenses for Corporate and Other
increased as a result of hiring new roles necessary as a public company and due
to $1.0 million of additional share-based compensation expense incurred during
2020.
Other Operating Expenses
The following table sets forth our other operating expenses by Operating Group
by amount and as a percentage of our other operating expenses:
                                            For the Three Months Ended March 31,
                                         2020                                   2019                           Variance
                                                                                                                      Percent
                                                                                                                       Change
                                                                                                                     from Prior
(in thousands)              Amount        Percent of Business      Amount       Percent of Business      Amount         Year
Other operating
expenses by Operating
Group
Middle Market           $      2,741                31 %         $   1,792                45 %         $     949           53 %
Specialty                      1,483                17 %               355                 9 %             1,128          318 %
MainStreet                       997                11 %               926                23 %                71            8 %
Medicare                         790                 9 %               473                12 %               317           67 %
Corporate and Other            2,874                32 %               456                11 %             2,418          n/m
                        $      8,885                             $   4,002                             $   4,883


__________
n/m not meaningful



                                                                              33

--------------------------------------------------------------------------------




Other operating expenses increased across all Operating Groups for the three
months ended March 31, 2020 as compared to the same period of 2019. These
increases were primarily attributable to the Partnership Contribution, which
accounted for $0.7 million, $1.0 million, $0.1 million and $0.2 million other
operating expenses in the Middle Market, Specialty, MainStreet and Medicare
Operating Groups, respectively, during 2020. The remainder of the increases in
the four Operating Groups were driven by organic growth.
Other operating expenses in Corporate and Other, including professional fees,
insurance, colleague education, travel and dues and subscriptions, increased
primarily as a result of being a public company.
Amortization Expense
The following table sets forth our amortization by Operating Group by amount and
as a percentage of our amortization:
                                             For the Three Months Ended March 31,
                                         2020                                     2019                           Variance
                                                                                                                         Percent
                                                                                                                       Change from
(in thousands)              Amount         Percent of Business       Amount       Percent of Business      Amount      Prior Year
Amortization by
Operating Group
Middle Market           $         571                16 %         $      301                34 %         $     270           90  %
Specialty                       2,366                66 %                267                30 %             2,099          n/m
MainStreet                        431                12 %                194                22 %               237          122  %
Medicare                          225                 6 %                 96                11 %               129          134  %
Corporate and Other                 3                 - %                 18                 2 %               (15 )        (83 )%
                        $       3,596                             $      876                             $   2,720


__________
n/m not meaningful


Amortization expense increased across all Operating Groups for the three months
ended March 31, 2020 as compared to the same period of 2019. These increases
were driven by intangible assets capitalized in connection with Partners
acquired since the first quarter of 2019 across all Operating Groups.
Change in Fair Value of Contingent Consideration
The following table sets forth our change in fair value of contingent
consideration by Operating Group by amount and as a percentage of our change in
fair value of contingent consideration:
                                      For the Three Months Ended March 31,
                                      2020                              2019                        Variance
                                                                                                           Percent
                                                                                                            Change
                                            Percent of                      Percent of                    from Prior
(in thousands)              Amount           Business         Amount         Business         Amount         Year
Change in fair value
of contingent
consideration by
Operating Group
Middle Market           $    (2,166 )             (130 )%   $  (2,118 )           76  %     $     (48 )          2 %
Specialty                     2,447                147  %        (518 )           19  %         2,965          n/m
MainStreet                    1,627                 98  %          15             (1 )%         1,612          n/m
Medicare                       (247 )              (15 )%        (165 )            6  %           (82 )         50 %
                        $     1,661                         $  (2,786 )                     $   4,447


__________
n/m not meaningful


The change in fair value of contingent consideration results from fluctuations
in the value of the relevant measurement basis, normally revenue or EBITDA of
our Partners. The Specialty and MainStreet Operating Groups recorded losses of
$2.1 million and $1.4 million, respectively, during the first quarter of 2020 as
a result of higher estimates for the contingent consideration liabilities of the
MSI and Foundation Insurance Partnerships related to growth of business.

                                                                            

34

--------------------------------------------------------------------------------




LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity needs for the foreseeable future will include cash to
(i) provide capital to facilitate the organic growth of our business and to fund
future Partnerships, (ii) pay operating expenses, including cash compensation to
our employees and expenses related to being a public company, (iii) make
payments under the Tax Receivable Agreement, (iv) pay interest and principal due
on borrowings under the JPMorgan Credit Agreement, (v) pay contingent earnout
liabilities, and (vi) pay income taxes. We have historically financed our
operations and funded our debt service and distributions to our owners through
the sale of our insurance products and services. In addition, we financed
significant cash needs to fund growth through the acquisition of Partners
through debt financing.
As of March 31, 2020, our cash and cash equivalents were $52.1 million. We
believe that our cash and cash equivalents, cash flow from operations and
available borrowings under the JPMorgan Credit Agreement will be sufficient to
fund our working capital and meet our commitments for the foreseeable future.
However, we expect that we will require additional funding to continue to
execute on our Partnership strategy. Such funding could include the incurrence
of additional debt or the issuance of equity. Additional funds may not be
available on a timely basis, on favorable terms, or at all, and such funds, if
raised, may not be sufficient to enable us to continue to implement our
long-term Partnership strategy. If we are not able to raise funds when needed,
we could be forced to delay or reduce the number of Partnerships that we
complete.
See Part II, Item 1A. "Risk Factors - The ongoing novel coronavirus (COVID-19)
pandemic could result in declines in business and increases in claims that could
adversely affect our business, financial condition and results of operations."
JPMorgan Credit Agreement
As of March 31, 2020, we had an aggregate borrowing capacity of $300.0 million
under the revolving credit commitment (the "Revolving Credit Commitment") of the
JPMorgan Credit Agreement, which matures on September 23, 2024 and of which no
more than $65.0 million is available for working capital purposes and the
entirety of which is available to fund acquisitions permitted under the JPMorgan
Credit Agreement. On March 12, 2020, we drew $20.0 million on the Revolving
Credit Commitment to utilize for working capital purposes in anticipation of the
potential effects of the COVID-19 pandemic. The outstanding balance of the
Revolving Credit Commitment was $60.4 million at March 31, 2020. On April 28,
2020, the Company converted $10.0 million of its borrowings previously drawn on
the Revolving Credit Commitment for working capital purposes to utilize such
proceeds for funding Partnerships closed on May 1, 2020.
The Revolving Credit Commitment is collateralized by a first priority lien on
substantially all the assets of the Company, including a pledge of all equity
securities of each of its subsidiaries. The interest rate of the Revolving
Credit Commitment is based on, depending on the type of loan, the Eurodollar
rate or the Alternative Base Rate, plus, in each case, a margin based on Total
Leverage Ratio (as defined in the JPMorgan Credit Agreement), as set forth in
the pricing grid below, provided that under no circumstances will the LIBO Rate
(as defined in the JPMorgan Credit Agreement) used in the determination of the
Eurodollar rate be less than 0.00% or the Alternate Base Rate be less than
1.00%:
                                                           Applicable Margin for
                                Applicable Margin for       Alternate Base Rate
  Total Net Leverage Ratio         Eurodollar Loans                Loans
          < 2.50x                      200 bps                    100 bps
      ? 2.50x < 3.00x                  225 bps                    125 bps
      ? 3.00x < 3.75x                  250 bps                    150 bps
          ? 3.75x                      300 bps                    200 bps


At March 31, 2020 and December 31, 2019, the variable rate in effect for the
JPMorgan Credit Agreement was the London Interbank Offered Rate ("LIBOR") due to
a pricing option and the applicable interest rate on the Revolving Credit
Commitment was 3.00% and 3.81%, respectively.
The JPMorgan Credit Agreement contains covenants that, among other things,
restrict our ability to make certain restricted payments, incur additional debt,
engage in certain asset sales, mergers, acquisitions or similar transactions,
create liens on assets, engage in certain transactions with affiliates, change
our business, make certain investments or restrict BRP's ability to make
dividends or other distributions to BRP Group.

                                                                            

35

--------------------------------------------------------------------------------




In addition, the JPMorgan Credit Agreement contains financial covenants
requiring us to maintain our Total Leverage Ratio (as defined in the JPMorgan
Credit Agreement) at or below 5.00 to 1.00 up to but excluding September 21,
2022 (with scheduled annual step downs to 4.75 to 1.00 and 4.50 to 1.00
beginning in 2022 and with step ups of 0.50 to 1.00 and 0.25 to 1.00 for the
first and second quarters, respectively, after any Material Acquisition (as
defined in the JPMorgan Credit Agreement)), Debt Service Coverage Ratio (as
defined in the JPMorgan Credit Agreement) at or above 2.00 to 1.00 up to but
excluding September 21, 2022 (with scheduled annual step ups to 2.25 to 1.00 and
2.50 to 1.00 beginning in 2022) and Senior Leverage Ratio (as defined in the
JPMorgan Credit Agreement) at or below 4.50 to 1.00 up to but excluding
September 21, 2022 (with scheduled annual step downs to 4.25 to 1.00 and 4.00 to
1.00 beginning in 2022 and with step ups of 0.50 to 1.00 and 0.25 to 1.00 for
the first and second quarters, respectively, after any Material Acquisition).
Contractual Obligations
The following table represents our contractual obligations, aggregated by type,
at March 31, 2020:
                                                            Payments Due by Period
                                                  Less than                                      More than
(in thousands)                       Total         1 year        1-3 years       3-5 years        5 years
Operating leases (1)              $  46,416     $     5,967     $   12,294     $     9,956     $    18,199
Debt obligations payable (2)         68,512           1,811          3,622          63,079               -
Maximum future acquisition
contingency payments (3)            119,325          23,709         94,678             938               -
Total                             $ 234,253     $    31,487     $  110,594     $    73,973     $    18,199

__________

(1) The Company leases facilities and equipment under noncancelable operating

leases. Rent expense was $1.2 million and $0.9 million for the three months

ended March 31, 2020 and 2019, respectively.

(2) Represents scheduled debt obligations and estimated interest payments.

(3) Includes $53.9 million of current and noncurrent estimated contingent earnout

liabilities at March 31, 2020.




Tax Receivable Agreement
We expect to obtain an increase in our share of our tax basis of the assets when
BRP's LLC Units are redeemed or exchanged for shares of BRP Group's Class A
common stock. This increase in tax basis may have the effect of reducing the
future amounts paid to various tax authorities. The increase in tax basis may
also decrease gains (or increase losses) on future dispositions of certain
capital assets to the extent tax basis is allocated to those capital assets.
We entered into a Tax Receivable Agreement on October 28, 2019 (the "Tax
Receivable Agreement") that provides for the payment by us to the parties to the
Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S.
federal, state and local income tax or franchise tax that we actually realize as
a result of (i) any increase in tax basis in BRP Group's assets and (ii) tax
benefits related to imputed interest deemed arising as a result of payments made
under the tax receivable agreement.
During the three months ended March 31, 2020, no distributions or redemptions
were made that triggered an increase in BRP Group's tax basis.
SOURCES AND USES OF CASH
The following table summarizes our cash flows from operating, investing and
financing activities for the periods indicated:
                                                     For the Three Months Ended March 31,
(in thousands)                                           2020                     2019             Variance
Net cash provided by operating activities        $           4,971         $           4,865     $      106
Net cash used in investing activities                      (39,888 )                 (36,188 )       (3,700 )
Net cash provided by financing activities                   19,811                    34,122        (14,311 )
Net increase (decrease) in cash and cash
equivalents and restricted cash                            (15,106 )                   2,799        (17,905 )
Cash and cash equivalents and restricted cash at
beginning of period                                         71,071                     7,995         63,076
Cash and cash equivalents and restricted cash at
end of period                                    $          55,965         $          10,794     $   45,171



                                                                              36

--------------------------------------------------------------------------------




Operating Activities
The primary sources and uses of cash for operating activities are net income
adjusted for non-cash items and changes in assets and liabilities, or operating
working capital. Net cash provided by operating activities increased $106,000
for the three months ended March 31, 2020 as compared to the same period of 2019
driven by a net increase in net income adjusted for non-cash items, offset in
part by a net decrease in cash flows provided by growing receivable balances and
losses in revenues from profit-sharing and fees.
Investing Activities
The primary sources and uses of cash for investing activities relate to cash
consideration paid for business combinations and asset acquisitions, as well as
capital expenditures. Net cash used in investing activities increased $3.7
million for the three months ended March 31, 2020 as compared to the same period
of 2019. Cash consideration paid for business combinations and asset
acquisitions increased $3.7 million primarily as a result of the four
Partnerships we completed during 2020.
Financing Activities
The primary sources and uses of cash for financing activities relate to the
issuance of our Class A common stock, borrowings from and repayment to our
credit agreements, payment of debt issuance costs, payment of contingent and
guaranteed earnout consideration, distributions and contributions, and other
equity transactions. Net cash provided by financing activities decreased $14.3
million for the three months ended March 31, 2020 as compared to the same period
of 2019. Net cash provided by borrowings from our Credit Agreements to fund
acquisitions decreased $28.8 million primarily as a result of borrowings to fund
the Lykes Insurance, Inc. Partnership during the first quarter of 2019, offset
in part by drawing $20.0 million on the Revolving Credit Commitment to utilize
for working capital purposes in anticipation of the potential effects of the
COVID-19 pandemic during the first quarter of 2020. This decrease in cash was
offset in part by cash payments of $12.5 million related to the repurchase of
membership interests from members during 2019.
CRITICAL ACCOUNTING ESTIMATES
In preparing our financial statements in accordance with GAAP, we are required
to make estimates and assumptions that affect the amounts of assets,
liabilities, revenue, expenses, disclosure of contingent assets and liabilities
and accompanying disclosures. We evaluate our estimates and assumptions on an
ongoing basis. These estimates are based on historical experience and various
other assumptions that we believe to be reasonable under the circumstances;
although, actual results may differ from these estimates and assumptions. To the
extent that there are differences between our estimates and actual results, our
financial condition, results of operations and cash flows will be affected.
There have been no material changes in our critical accounting policies during
the three months ended March 31, 2020 as compared to those disclosed in the
Critical Accounting Estimates section under Management's Discussion and Analysis
of Financial Condition and Results of Operations of our Annual Report on Form
10-K filed with the SEC on March 24, 2020.
EMERGING GROWTH COMPANY STATUS
We are an emerging growth company, as defined in the Jumpstart Our Business
Startups ("JOBS") Act, and we may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies
that are not emerging growth companies. Section 107 of the JOBS Act provides
that an emerging growth company can take advantage of the extended transition
period for the implementation of new or revised accounting standards. We have
elected to use the extended transition period for complying with new or revised
accounting standards and as a result of this election, our financial statements
may not be comparable to companies that comply with public company effective
dates. We have also elected to take advantage of some of the reduced regulatory
and reporting requirements of emerging growth companies pursuant to the JOBS
Act, including not being required to comply with the auditor attestation
requirements of Section 404(b) of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation and exemptions from the
requirements of holding non-binding advisory votes on executive compensation and
golden parachute payments, if applicable.
We may take advantage of these exemptions up until the last day of the fiscal
year following the fifth anniversary of our initial public offering or such
earlier time that we are no longer an emerging growth company. We would cease to
be an emerging growth company if we have more than $1.07 billion in annual
revenue, we have more than $700.0 million in market value of our stock held by
non-affiliates (and we have been a public company for at least 12 months and
have filed one annual report on Form 10-K) or we issue more than $1.0 billion of
non-convertible debt securities over a three-year period.

                                                                            

37

--------------------------------------------------------------------------------




RECENT ACCOUNTING PRONOUNCEMENTS
Please refer to Note 1 to our condensed consolidated financial statements
included in Part I, Item 1. Financial Statements of this report for a discussion
of recent accounting pronouncements that may impact us.

© Edgar Online, source Glimpses